Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Posts about

Statistics and Programming

Veristat Congratulates Origin Biosciences for FDA Approval

Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare...

Veristat Expands Biometrics Capabilities by Acquiring SQN Clinical

Builds on a shared pedigree of data management, statistics and programming excellence across all...

Veristat Expands Operations into Taiwan

Veristat Expands Operations into Taiwan to Support Growing Client Demand for Clinical Trial,...

Veristat Supports Antibe Therapeutics for Pain and Inflammation Study

Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately...

Veristat Congratulates Alnylam on the FDA Approval of ONPATTRO™

Continues Collaboration to Provide Regulatory Submission Support for Additional Patisiran...

Veristat Congratulates Agios on the FDA Approval of TIBSOVO®

The First Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and...